[Treatment of rheumatic diseases with a new pyrazolone combination (diphenyldioxypyrazolidine-aminophthenazone)].
D010129:4-Aminobenzoic Acid / Q000627:therapeutic use*; D000632:Aminopyrine / Q000627:therapeutic use*; D006801:Humans; D010653:Phenylbutazone / Q000031:analogs & derivatives; D047069:Pyrazolones; D012216:Rheumatic Diseases / Q000628:therapy*
D047069:Pyrazolones; D000632:Aminopyrine; C038362:pyrazolone; D010653:Phenylbutazone; D010129:4-Aminobenzoic Acid
AMINOPYRINE/therapeutic use; PARA-AMINOBENZOIC ACID/therapeutic use; PHENYLBUTAZONE/related compounds; RHEUMATISM/therapy
Il trattamento delle malattie reumatiche con un nuovo composto pirazolonico (difenildiossipirazolidina-aminofenazone).